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1. Introduction  
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an established treatment. 
More than 15,000 procedures are performed worldwide each year for a number of 
hematological malignancies such as acute myeloid and lymphoid leukemia, and bone 
marrow failure syndromes (Gratwohl et al. 2002; Frassoni, 2004). It is predicted that 
transplantation rates for allo-HSCT will continue at the same or higher level in the 
immediate future (Gratwohl et al. 2002). Despite clinical cure in 20-70% of all patients, 
depending on disease presentation, long term sequelae of immunosuppression, 
chemotherapy toxicities and graft-versus-host disease (GvHD) debilitate a large number of 
patients (Gratwohl et al. 2002). Moderate to severe GvHD develops in 40-50% of patients 
undergoing allo-HSCT (Bearman et al. 1988; Weisdorf et al. 1990; Roy et al. 1992; Hings et al. 
1994). Factors limiting the efficacy of this treatment are death due to recurrence or 
treatment-related death due to infection or organ failure in the cytopenia and later 
immunosuppressed phase immediately post-HSCT. Over the last decades, the cumulative 
effects of improvements in supportive care, drug dosing, stem cell technology and 
prophylaxis of GvHD have led to an increased number of complete remissions (Devergie, 
2004). However, with the increasing number of transplants performed and the growing 
number of survivors, a shift in clinical focus from not only improving survival but also 
improving short and long-term quality of life has emerged (Andrykowski et al. 1995). 
Patients in the treatment and recovery phase of HSCT commonly experience adverse 
physical and emotional reactions. Fatigue and muscle weakness can limit ability to 
accomplish activities of daily living. Additionally, depression, anxiety, fear, and frustration 
add to the difficulties of recovering from HSCT (Syrjala et al. 1993; Andrykowski et al. 1995). 
Several studies confirm that high levels of physical and psychological stress have been 
observed in patients prior to and at the start of HSCT and during follow-up periods (Baker 
et al. 1997; Molassiotis & Morris, 1997; McQuellon et al. 1998; Fife et al. 2000). The 
mechanisms are not fully known, but it is assumed that several factors such as total body 
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irradiation (TBI), chemotherapy, GvHD, infections, long-term inactivity or bed rest and side-
effects from medication can contribute to the physical and emotional weakening of the 
patient. Recipients of allo-HSCT with low Vitamin D levels and low bone mineral density 
were likely to have received corticosteroids, have experienced GVHD and an elevated 
parathyroid hormone level (Sproat et al. 2011; Massenkeil et al. 2001). Vitamin D 
insufficiency and deficiency can cause osteomalacia, bone pain, muscle weakness, 
musculoskeletal pain, headache, fatigue, and may precipitate or exacerbate osteopenia and 
osteoporosis and increase risk of skeletal fracture (Knutsen et al. 2010; Sproat et al. 2011). 
Patients that have undergone HSCT experience treatment-related symptoms during and 
after treatment that can affect health related quality of life (HR-QOL). Patients experience 
multiple somatic, affective and cognitive symptoms during and after aggressive cancer 
treatment, where eleven to thirteen simultaneously occurring symptoms have been reported 
(Portenoy et al. 1994). During hospitalization for standard allo-HSCT, patients are typically 
on prolonged bed rest, and experience complications from the myeloablative treatment, ie. 
acute GvHD, side effects from medications (immunosuppression & steroids), frequent 
infections and psychological reactions that can be debilitating. It is reported that HR-QOL is 
lowest during inpatient time (Grulke et al. 2011). The most commonly reported symptoms 
are fatigue, diarrhea, insomnia, poor appetite, diminished concentration, mouth dryness, 
dyspnoea, loss of hair and poor body image perception (Jarden et al. 2009; Molassitis et 
al.1997; Larsen et al. 2007). After HSCT, fatigue, dyspnoea and insomnia remain at elevated 
levels (Grulke et al. 2011). Psychosocial wellbeing after transplant is influenced by mucositis 
toxicity, and other side effects, and psychological factors as anxiety, distress and social 
support have a significant impact on how severely patients experience mouth pain (Schulz-
Kindermann et al. 2002) Fatigue is one of the most frequent and distressful side effects 
reported by patients who have undergone HSCT (Jarden et al. 2009; So et al. 2003), and it 
has been shown that physical activity decreased and this decline coincided with diminished 
physical, emotional, role and cognitive functioning during the initial post transplantation 
period (Danaher et al. 2006). Bevans et al. found that patients experienced multiple 
symptoms and high symptom distress after allo-HSCT conditioning (Bevans et al. 2008) 
Further, fatigue was the main symptom interfering with daily life in 79% of patients 
(Molassiotis & Morris, 1999), and in 11% of patients at 100 days post allo-HSCT (Bevans et 
al. 2008). Loss of physical strength seem to be more pronounced in patients on corticosteroid 
treatment, and the causes of an impairment of physical performance are not fully 
understood, though low activity levels have been suggested to be a substantial contributor 
(Carlson et al. 2006). One study in patients undergoing HSCT showed a correlation between 
the number of symptoms experienced and poor functional status and general health (Larsen 
et al. 2007) and in another study, changes in HRQoL could be explained entirely by changes 
in functional limitations and somatic symptoms (Broers et al. 2000). Further, symptom 
bother from GVHD had a direct effect on functional performance (Mitchell et al. 2010). A 
Danish study found patients prior to allo-HSCT to have lower VO2 max scores and elevated 
fatigue levels than the normal population, and these scores were unchanged six months 
after transplantation (Kalo et al. 2007). Furthermore, persons diagnosed with hematological 
disease have difficulty returning to the work force (deBoer et al. 2008) and have an increased 
risk for early retirement (Carlsen et al. 2008), while unemployed leukaemia patients, 
especially those with lower social support have significantly elevated levels of stress, 
anxiety, and depression (deBoer et al. 2008). In HSCT, predictors of slower return to work 
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include physical dysfunction and female gender (Kirchhoff AC et al. 2010). Maintaining 
daily function and reducing fatigue and treatment-related symptoms can be important goals 
and there is therefore, a continued need for nonpharmacological strategies that address the 
specific impairments experienced by patients undergoing allo-HSCT. 
There is a rapidly increasing literature on the effects of exercise on cancer rehabilitation, 
especially for breast cancer patients, on whom the majority of research has been conducted 
(Courneya et al. 2011, Conn et al. 2006). Despite that physical exercise showed positive 
effects on cardiorespiratory fitness, treatment-related symptoms and physiological effects, 
the extent of these positive results still need to be established. A qualitative and quantitative 
review and meta-analysis found only small to moderate effect of physical activity 
interventions on these outcomes (Schmitz et al. 2005; Conn et al. 2006). Physical activity is 
reported as being well tolerated in cancer survivors during and after treatment, however, 
conclusions about adverse effects are inconclusive (Schmitz et al. 2005). Recent guidelines 
for exercise prescription for cancer survivors from the American College of Sports Medicine 
(Schmitz et al. 2010) report no contraindication for starting an exercise program in patients 
undergoing either autologous or allogeneic HSCT – however, issues regarding, the ideal 
time for starting a program safely and effectively, type of program, frequency, intensity and 
duration is not confirmed, especially in relation to the HSCT treatment trajectory. Exercise 
has been proposed as a nonpharmacologic adjuvant therapy to combat the physiological 
and psychological symptoms of HSCT (Wiskemann & Huber, 2008). However, little work 
exists in utilizing exercise interventions specifically in the allo-HSCT setting. It is 
documented that there is a decline in exercise levels in cancer patients from prediagnosis to 
postdiagnosis (Courneya et al.1997) and more specifically, a low level of “naturally-
occurring” exercise amongst patients undergoing HSCT is reported, suggesting that a 
structured intervention may be necessary in order to promote exercise in this population 
(Courneya et al. 2000). The majority of the earlier research done in adult patients with 
hematological disease is in the context of high dose chemotherapy with stem cell support 
(autologous HSCT or HD-SCS). To date, there are eight published studies that incorporated 
exercise regimes in the high dose chemotherapy-stem cell support context (HD- SCS) 
(Coleman et al. 2003; Decker et al 1989; Hayes et al. 2003, Dimeo et al. 1996, 1997, 1999, 2003, 
including one on-going study (Peerson et al. 2010), and five studies in mixed HD-SCS and 
allo-HSCT populations (Dimeo et al. 1999, Baumann et al. 2005; Wilson et al. 2005, Knols et 
al. 2010, Danaher Hacker et al. 2011). There are however fundamental and important 
differences in the two types of treatment (HD-SCS and allo-HSCT) including the 
conditioning regimes, i.e. total body irradiation in allo-HSCT, and origin of stem cells, i.e. 
patients undergoing HD-SCS are supported with their own stem cells, and therefore the 
donor related challenges (GvHD) in allo-HSCT are not present, and lastly, the overall 
duration of hospitalization for HD-SCS is much shorter compared to allo-HSCT. One 3 year 
prospective study, found that patients undergoing HD-SCS had better self-rated physical 
function (symptomotology, physical status and energy level) as compared to the allo-HSCT 
group (Prieto et al 2005). The HD-SCS and mixed group (HD-SCS and allo-HSCT, and age) 
exercise-based study sizes ranged between 12-70 participants. There are five randomized 
trials (Peerson et al. 2010; Baumann et al. 2005; Coleman et al. 2003; Hayes et al. 2004; Dimeo 
et al. 1996), one study used a minimization procedure (Knols et al. 2010) and six single-
group trials (Danaher Hacker et al. 2011; Wilson et al. 2005; Decker et al 1989; Dimeo et al. 
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1997, 1999, 2003). Exercise was tested during hospitalization in three studies ( Baumann et 
al. 2005; Dimeo et al. 1996; 2003), one study during hospitalization and continued to out-
patient (Dimeo 1999), and eight studies after hospital discharge (outpatient and home based 
programs) (Wilson et al. 2005; Decker et al 1989; Coleman et al. 2003; Hayes et al. 2004; 
Dimeo et al. 1997, Knols et al. 2010; Peerson et al. 2010; Danaher Hacker et al. 2011). 
Feasibility was established, no adverse events registered and beneficial effects were reported 
on aerobic capacity (Hayes et al. 2004; Dimeo et al. 2003; Dimeo et al. 1996); muscle strength 
(Hayes et al. 2004; Knols et al. 2010), body composition (Coleman et al. 2003; Hayes et al. 
2003), immunological function (Dimeo et al. 1997; Hayes et al. 2003; Knols et al. 2010), 
treatment-related symptoms i.e. fatigue (Dimeo et al. 1999; Wilson et al. 2005) and HRQoL 
(Wilson et al. 2005; Hayes et al. 2004). These positive and potentially important results for 
HD-SCS and mixed groups are encouraging, but we need to look exclusively at the allo-
HSCT adult patient group in order to evaluate the role and impact of exercise rehabilitation 
in this treatment context alone.  
The primary objective of the systematic review is to summarize the exercise-based 
rehabilitative interventions in adults with haematological disease undergoing allogeneic 
hematopoetic stem cell transplantation (allo-HSCT) on feasibility and safety, and 
effectiveness related to physical and functional capacity, health related quality of life, 
treatment-related symptoms and medical related outcomes.  
2. Method  
The systematic literature search is based on PRISMA guidelines (preferred reporting items 
for systematic reviews and metaanalyses) developed from Cochrane Collaboration (Moher 
D et al. 2009).This review includes 1) a systematic literature search with the identification of 
all intervention trials in adult patients in the allo-HSCT setting during the past 25 years, 2) a 
uniform presentation of all trials and a synthesis of the characteristics and findings, 3) an 
appraisal of the methodological quality of the trials, 4) a summary and 5)  conclusions and 
future research.   
2.1 Search strategy and data extraction  
The systematic literature review covers 25 years of research: 1986 – 2011 (Table 1). Searches 
were carried out in MEDLINE and EMBASE using search items bone marrow cell 
transplantation, bone marrow transplantation, stem cell transplantation, physical activity, 
physical fitness and exercise. Identified articles were searched for additional references. The 
search was limited to include randomized controlled trials (RCT), controlled clinical trials, 
adults and English articles. Eligibility criteria are shown in Table 2. Only studies that 
included patients from the allogeneic setting are included in this review. Studies that 
included patients in either the auto-HSCT / HD-SCS setting or mixed settings (both 
autologous and allogeneic) were excluded, though compiled in the literature search for 
background and reference purposes. Full articles were obtained for remaining abstracts and 
information was extracted from identified articles and organized under the following 
headings: authors, sample (n, type of treatment), age, design and study period, exercise-
based intervention, duration, frequency/intensity, and results (Table 3). All articles were 
independently reviewed and appraised for rigor of method and analysis.  
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Date Search Limits Database Results 
1/7/2011 "Bone Marrow Cell Transplantation"
"Bone Marrow Transplantation" 
"Stem Cell Transplantation" 
 
Allogeneic[tw] 
Autologous[tw] 
 
"Physical activity" 
"Physical fitness" 
 “Exercise” 
 
English 
 
Publication date 
from 1986/01/01 
to 2011/07/01 
Medline (NLM) 90 
("Bone Marrow Cell Transplantation" OR "Bone Marrow Transplantation" OR "Stem Cell 
Transplantation") AND (Allogeneic OR Autologous[ AND ("Physical activity" OR "Physical 
fitness" OR Exercise) AND (English[lang] AND ("1986/01/01" : "2011/07/01") 
Date  Search Limits Database Results 
1/7/2011 "Bone Marrow Cell Transplantation".
"Bone Marrow Transplantation". 
"Stem Cell Transplantation". 
 
"Allogeneic" 
"Autologous". 
  
"Physical activity". 
"Physical fitness" 
 "Exercise" 
 
English language
 
Publication year: 
1986-Current 
EMBASE 
(OvidSP) 
90 
(("Bone Marrow Cell Transplantation" or "Bone Marrow Transplantation" or "Stem Cell 
Transplantation") and ("Allogeneic" or " Autologous") and ("Physical activity" or "Physical 
fitness" or "Exercise")), (English[lang] AND ("1986/01/01" : "2011/07/01") 
Table 1. Results of a systematic literature search with keywords 
 
 Inclusion criteria  Exclusion criteria 
 Journal articles reporting primary research of
exercise-based intervention studies prior to,
during or after allo-HSCT 
 Randomized clinical trials or controlled studies 
 Participants >18 years  
 Recipients of allo-HSCT for a hematologic 
disease   
 Published in English between 1986 and 2011 
 Studies that include auto-HSCT/HD-SCT 
 Studies that include a mixed population of 
auto-HSCT and allo-HSCT 
 Review articles or case study 
 Clinical reports  
 Dissertations  
 Conference abstracts 
 Editorials or letters to the editor 
Allo-HSCT indicates allogeneic stem cell transplantation; auto-SCT, autologous stem cell 
transplantation; HD-SCT, high dose chemotherapy with stem cell support 
Table 2. Eligibility criteria  
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AA indicates aplastic anemia, AML, acute myelogenous leukemia; ALL, acute lymphocytic or lymphoblas
lymphocytic leukemia; CML, chronic myelogenous leukemia; CMML, chronic myelomonocytic leukemi
myelodysplastic syndrome; MF, myelofibrosis; MM,  multiple myeloma; MPS, myeloproliferative syndro
lymphoma; PNH, paroxysmal nocturnal hemoglobinuria; WM, waldenstrom macroglobulinemia 
RPE, Rate of Perceived Exertion; St.v, Stroke Volume; HR, Heart Rate; IG, Intervention Group; IG2, Inter
Group; TPN, Total Parenteral Nutrition; 
MHR, Maximal Heart Rate; DM and NDM, Dominant Non Dominant; KPS, Karnofsky Score; PT, Physic
outcome; HR-QoL, health related Quality of Life; TR-symptoms, treatment related symptoms; SCT-SAS
Symptom Assessment Scale; EORTC-QLQ-C30 European Organization for Research and Treatment of C
Questionnaire; HADS, Hospital Anxiety and Depression Scale; FACT-An or FACT-F, Functional Assess
or Fatigue scale; POMS, Profile of Mood States; MFI, Multidimensional Fatigue Inventory; BFI, Brief Fat
Depression Inventory; STAI, State Trait Anxiety Inventory; 6MWD, 6 minute walk distance , → no chan ↑ ↓
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3. Results  
3.1 Exercise-based studies in the allo-HSCT setting 
In this review, 10 studies met the inclusion criteria (Baumann et al. 2011; Carlson et al. 2006; 
Cunningham et al. 1986; Defor et al. 2007; Inoue et al., 2010; Jarden et al., 2009; Kim and Kim 
2006; Mello et al. 2003; Shelton et al. 2009; Wiskemann et al. 2011). Of these, three were from 
the USA and two from Germany, and respectively, one from Brazil, Canada, Denmark, 
Japan and South Korea. Cunningham et al. carried out the very first exercise training trial 
for the allo-HSCT population in 1986 and although the participants included children and 
adults (range 14 – 41 years), this study is included in the review because of its focus being in 
the allo-HSCT setting only. Jarden et al. published three articles and Kim et al. two articles, 
each based on one trial, however each article has a different focus and purpose.  
All studies were designed as prospective intervention trials that tested an exercise-based 
program. The primary and secondary outcomes were study feasibility and safety; 
physiological outcomes i.e. aerobic, muscle strength and function; psychosocial outcomes 
i.e. health-related QoL, emotional wellbeing; treatment-related symptoms i.e. fatigue; and 
hospital or disease-related outcomes i.e. days of hospitalization, creatinine excretion, 
lymphocyte counts. Baseline to post assessment ranged between 4 – 16 weeks [mean 7.3] and 
one study had follow-up tests to 6 months (Jarden et. al. 2009).  
3.2 Sample characteristics  
In all, 406 patients with different haematological diseases (AA,, AML, ALL, CLL , CML, 
CMML, FL, HD, MDS, MF, MM, MPS, NHL, PNH, WM, other lymphomas)1 across 10   
 
 
Table 4. Intervention phase 
                                                 
1 AA indicates aplastic anemia, AML, acute myelogenous leukemia; ALL, acute lymphocytic or 
lymphoblastic leukemia ; CLL, chronic lymphocytic leukemia; CML, chronic myelogenous leukemia; 
CMML, chronic myelomonocytic leukemia; HD, Hodgkins disease; MDS, myelodysplastic syndrome; 
MF, myelofibrosis; MM,  multiple myeloma; MPS, myeloproliferative syndrome; NHL, Non-Hodgkin 
lymphoma; PNH, paroxysmal nocturnal hemoglobinuria; WM, waldenstrom macroglobulinemia 
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studies are included in this review. The sample size of the studies ranged from 12 to 105 
[Mean 50.7] and the patients were of mixed gender between 14 and 71 years [mean 42.6]. 
Cunningham was the only study that included patients less than 18 years of age. Four 
studies were initiated prior to conditioning and throughout the hospitalization period 
(Baumann et al. 2011; Cunningham et al. 1986; Defor et al. 2007; Jarden et al. 2009; Kim and 
Kim 2006; Wiskemann et al. 2011), two studies after marrow engraftment and throughout 
hospitalization (Mello et al., 2003; Inoue et al., 2010), and three of these continued post allo-
HSCT (Defor et al. 2007; Mello et al. 2003; Wiskemann et al. 2011). Two studies were 
initiated post allo-HSCT in the out-patient or home setting, within 6 and 39 months (range 9-
92), respectively (Shelton et al. 2009; Carlson et al. 2006). The approximate start and 
endpoint of each intervention is illustrated in Table 4.  
3.3 Type of exercise-based interventions 
The duration of the exercise-based interventions ranged between 4-16 weeks [mean 7.3]. 
For interventions initiated prior to and during hospitalization, 6 of the studies were 
supervised (Cunningham et al. 1986; Mello et al. 2003; Kim and Kim 2006; Jarden et al. 
2009; Inoue et al. 2010; Baumann et al. 2011) and 2 were partly supervised (DeFor et al. 
2007, Wiskemann et al. 2011). In the out-patient context, Carlson’s study was fully 
supervised, while Shelton’s study had one supervised and one self-directed study arm. 
The frequency of all interventions ranged between 3 and 5 days/week or daily. When 
reported, the intensity of training in general was between low/mild and comfortable to 
moderate but not exceeding 70-75% of maximum heart rate or in Rate of Perceived 
Exertion (RPE) - being somewhat hard.     
In the in-patient context, one study tested strength resistive training (Cunningham et al. 
1986), one a walking program (treadmill or walking) (Defor et al. 2007) and another mixed-
type low intensity bed exercises of stretching and relaxation breathing (Kim and Kim 2006), 
and 5 studies instituted mixed-type exercise up to moderate intensity (Mello et al. 2003, 
Jarden et al. 2009, Inoue et al. 2010, Wiskemann et al. 2011, Baumann et al. 2011) by 
combining aerobic training (treadmill, cycle, walking or stair climbing) with one or more 
other moderate intensity exercise (range of motion or ADL (activities of daily living), 
coordination exercises, muscle stretching, resistive exercises with free weights or elastic 
bands) and low intensity progressive relaxation training and education (Jarden et al. 2009). 
Three studies (Mello et al. 2003; Wiskemann et al. 2011, Defor et al. 2007) continued the 
programs after hospital discharge. In the out-patient only context, one study tested an 
ergometer cycle program (Carlson et al. 2006), and the other, aerobic (cycle or treadmill) and 
resistive exercises (weight machines) vs. selfdirected walking and resistive exercises 
including patient information regarding exercise safety (Shelton et al. 2009). All in all, three 
studies were unidimensional (one exercise component), of which, two were aerobic training 
(Carlson et al. 2006; DeFor et al. 2007), and one resistance training (Cunningham et al. 1986), 
and seven studies had mixed type training (Baumann et al. 2011; Inoue et al. 2010; Jarden et 
al. 2009; Kim and Kim 2006; Mello et al. 2003; Shelton et al. 2009; Wiskemann 2011), of 
which, one was of low intensity (Kim and Kim 2006), and one study included both low and 
moderate intensity components (Jarden et al. 2009). Only two studies incorporated 
educational (Shelton et al. 2009) or psychoeducational (Jarden et al. 2009) elements in the 
program.    
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3.4 Feasibility and safety  
No adverse events, reactions or injuries were reported, though not all studies reported 
safety outcomes. The overall attrition rates ranged between 0 and 44% (mean 18.7). Program 
compliance was reported by five studies (Carlson et al. 2006; DeFor et al. 2007; Jarden et al. 
2009; Shelton et al. 2009; Wiskemann et al. 2011). Carlson et al. reported an overall 89% 
compliance. Defor et al. reported that 24% of all patients had 100% compliance and that 62% 
of the study’s population exercised at least 5 times/wk for at least 15 min during 
hospitalization and after discharge, respectively. Jarden et al. reported 90% intervention 
compliance (range 67-100), and 83% in-hospital and 87% at-home compliance (Wiskemann 
et al. 2011), while Shelton et al. reported 75% for the supervised intervention, though did not 
report for the self-directed intervention. Some studies had safety screening parameters, in 
which contraindication for exercise included platelet counts <10 and 20 x 109/l 
(Cunningham et al. 1986, Mello et al. 2003, Jarden et al. 2009; Wiskemann et al. 2011, 
Baumann et al. 2011), and haemoglobin <5 g/dl (Jarden et al. 2009), <8 (Wiskemann et al. 
2011, Baumann et al. 2011), and <10 (Mello et al. 2003); temp>38oC (Cunningham et al. 1986; 
Jarden et al. 2009; Wiskemann et al. 2011, Baumann et al. 2011), and adverse symptoms as 
bleeding, petecchiae, pain, nausea, dizziness. Baumann et al. interrupted training during 
cardio and nephrotoxic chemotherapy.  
3.5 Physiological outcomes - aerobic/endurance  
A mixed-type exercise program 5 days/week at moderate intensity during the entire 
hospitalization was able to maintain aerobic capacity, while the control group decreased, 
and this difference was highly significant (p<0.01) (Jarden et al. 2009). Another similar 
mixed-exercise program during hospitalization showed a significant decrease in aerobic 
endurance (p=0.009) in the control group, but no significant difference between intervention 
and control groups (Baumann et al. 2011). A 12 wk. aerobic training program on cycle 
ergometer initiated between 9 and 92 months after HSCT showed cardiovascular effects 
through increased stroke volume (p<0.005) and decreased heart rate (p<0.005), with a 
decreased RPE (p<0.005) (Carlson et al. 2006). 
3.6 Muscle strength 
Mello et al. combined aerobic (treadmill) and ROM exercise program initiated during 
hospitalization and continued into the outpatient facility over 6 weeks showed significant 
decrease in upper and lower extremity strength in the control group, however differences 
between intervention and control groups were not significant.  
During hospitalization, four muscle strength tests (chest press 1 RM, leg extension 1 RM, 
elbow flexor and knee extensor Newton) decreased by 2 - 4 % in the intervention group, 
while decreasing between 19 - 25 % in the control group. This difference was significant 
(p<0.01) (Jarden et al. 2009). Baumann et al., however, did not find a significant difference 
between groups for muscle strength, but the pre to post muscle strength scores decreased 
significantly in the control group (p=0.022).  
3.7 Functional capacity  
Wiskemann et al. maintained the 6 minute walk distance (6MWD) in the intervention group, 
while the control group decreased and the intergroup difference was significant (p=0.02). 
The 2 minute stair climb test in the intervention group decreased by 14 % and for the control 
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group 38%, and the difference between groups was significant (p<0.01) (Jarden et al. 2009). 
A walking program did not show significant differences between groups for the Karnofsky 
score, though a subgroup analysis of the nonmyeloablative conditioned patients showed 
that this patient group decreased significantly less than the control group (p=0.04) (DeFor et 
al. 2007). There were no significant differences for the 6MWD between a supervised and self 
directed intervention, still both groups significantly improved by 12% (p<0.05) and 9.8% 
(p<0.05), respectively (Shelton et al. 2009). Also, the supervised group improved the 50 foot 
walk time (p=0.05) and maintained other performance tests, though no significance between 
groups.  
3.8 Health-related quality of life 
A bed exercise study with relaxation breathing, ROM and stretching during hospitalization 
decreased depression (BDI) p=0.0001 and anxiety (STAI) p=0.0001 as compared to the 
control group (Kim and Kim 2006). An in- to out-patient walking program showed 
improvements in physical and emotional wellbeing on a self reported score from 1 – 10, 
with 1 being very poor and 10 being very good. At discharge, physical wellbeing was better 
in the exercise group (p<0.01). Among the nonmyeloablative group, emotional wellbeing 
was better in the exercise group (p=0.02) at discharge and at 100 days, physical wellbeing 
was superior in the exercise group (p<0.01) (DeFor et al. 2007). A mixed exercise 
intervention during the entire hospitalization showed no difference in QoL and emotional 
wellbeing between groups (EORTC-QLQ-C30, FACT-An, HADS), though HRQOL was 
maintained in the intervention group at post testing, and there was significant improvement 
in emotional wellbeing at 3 and 6 months, p=0.045 and p=0.012, respectively (FACT-An) and 
significant decrease in anxiety at 3 and 6 months, p=0.021 and p<0.0001, respectively 
(HADS). The control group significantly decreased overall HRQOL p=0.0005 (FACT-An) at 
post testing, and significantly reduced physical functioning (p=0.004) and worsened three 
gastrointestinal symptoms (nausea and vomiting (p=0.048), appetite loss (p=0.004) and 
diarrhea (p=0.011) (EORTC QLQ C-30) (Jarden et al. 2009). Wiskemann et al. study beyond 
discharge showed between group differences in favor of the intervention group in physical 
functioning (p=0.03)(EORTC-QLQ-C30) and decreased depression (p=0.05), though showed 
a significant  increase in anxiety (p=0.01) in the intervention group (HADS). Baumann et al. 
found no significant difference between groups on the EORTC-QLQ-C30, though the pre-
post differences in the intervention and control group decreased significantly for physical 
functioning (p=0.005 and p=0.002). Intervention group improved emotional state (p=0.028), 
but again, no differences between groups (Baumann et al. 2011). Carlson et al.’s out-patient 
endurance program significantly improved intergroup vigor scores (p<0.001) on POMS.  
3.9 Treatment-related symptoms  
There was a decreased symptom prevalence in diminished concentration, memory loss, 
nausea and nervousness (p<0.01) and decreased symptom severity in fatigue, loss of 
appetite, sleep difficulties and nausea (p<0.05) on the SCT-SAS scale (Jarden et al. 2009). 
Further, diarrhea was significantly decreased (EORTC-QLQ-C30) (p=0.014) (Jarden et al. 
2009). Symptom cluster analyses revealed a significant decrease in symptom severity in 
gastrointestinal, cognitive, functional and mucositis clusters over time and up to 6 months 
after allo-HSCT (p<0.01). Wiskemann et al. found a significant decrease between groups in 
both general and physical fatigue (p=0.009, p=0.01) MFI and a significant decrease in fatigue 
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(p=0.01) (POMS). Baumann et al. was unable to show between group differences in fatigue 
scores, but the control group increased fatigue at post testing (p=0.046). Carlson et al. 
showed a significant decrease in fatigue (p<0.001) (BFI and FACT-F). 
3.10 Medical related outcomes 
Cunningham et al. did not find significant changes in body composition, though a 
decreased creatinine excretion in the intervention group (Cunningham et al. 1986). Kim et 
al. tested a bed exercise effect on lymphocyte counts, and reported no significant 
differences between groups, however there was an interaction between groups and times 
(p=0.031), there was also a decrease in lymphocyte count in the control group (p<0.05). 
Jarden et al. reported the intervention group as receiving fewer days of TPN (p=0.019) 
with no changes in BMI between groups at post testing. There were no other differences 
between groups regarding hospitalization days, bone marrow engraftment days, days 
with fever, and though there was a 19% difference in the incidence of GvHD favoring the 
intervention group, this was not statistically different. Defor et al. and Inoue et al. showed 
no difference in days of hospitalization between groups, but Inoue et al. showed that the 
degree of physical activity had a negative correlation with the duration of hospitalization 
(r=-.71; p=0.0071). 
3.11 Methodological quality of the studies 
Seven studies were designed as randomized trials (Cunningham et al. 1986; Mello et al. 
2003; Kim and Kim 2006; Defor et al. 2007; Jarden et al. 2009; Shelton et al. 2009; Baumann et 
al. 2011), one study allocated through the minimization method (Wiskeman et al. 2011), one 
study was a convenience sample studying the effect of the same exercise intervention on 
two different allo-HSCT treatment groups (myeloablative or nonmyeloablative conditioning 
regime) (Inoue et al. 2010) and one study did not have a control group (Carlson et al. 2006). 
Further, Shelton et al. studied the effect of two different interventions (supervised vs. self 
directed) in the outpatient/home setting. The control group was described in most studies 
as receiving standard or usual care, including either no formal training or the hospital units’ 
standard physical therapy (PT). Generally, standard PT was described as being introduced 
later during hospitalization, i.e. after stem cell infusion, and at less frequent intervals and 
lower intensity levels. The study arms were not similar at baseline in two (Kim and Kim 
2006; Baumann et al. 2011) of the eight groups in which there was an intervention and 
control group present. The control group in Kim et al. had a significant higher lymphocyte 
level at baseline compared to the intervention group and Baumann et al. had twice as many 
males as females in the exercise group as compared to the control group at baseline. All 
studies reported the eligibility criteria to which the study population was chosen. Only one 
study stated that the outcome assessor was blinded (DeFor et al. 2007). In the relevant 
studies, none reported blinding of the exercise trainer or the patients. Two studies reported 
performing intention-to-treat analyses (Jarden et al. 2009; Wiskemann et al. 2011).  
4. Summary 
This is the first literature review of exercise-based interventions in the allo-HSCT context. 
The purpose of this systematic review was to summarize the exercise-based rehabilitative 
interventions in adults with haematological disease undergoing allogeneic hematopoetic 
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stem cell transplantation (allo-HSCT) on feasibility and safety, and effectiveness related to 
physical and functional capacity, health related quality of life, treatment-related symptoms 
and medical related outcomes. To date, 10 intervention studies and 13 articles have been 
published that incorporated exercise-based regimes in the allo-HSCT context, and though 
we have found encouraging and important results, making direct trial comparisons can be a 
challenge due to the small sample sizes, the wide range of different primary and secondary 
outcomes and measurements, varying types of interventions, and different start and end 
points, duration, frequency and intensity of the different exercise components. Most of the 
studies in this review were randomized trials, however, control groups received varying 
standard care regimes, and there was a lack of outcome assessor blinding, trainer blinding 
and patient blinding which decreases the general methodological quality of the studies. 
Taking these methodological limitations into consideration, this review however finds 
important results pertinent to the allo-HSCT clinical setting.  
The results suggest that exercise interventions are feasible and safe. No study reported 
adverse events as a direct result of testing or exercising, though not all studies reported 
safety. Five studies reported safety screening parameters, which may have contributed to 
patients being able to exercise safely. Of the five studies that reported compliance rates, it 
would suggest that patients are capable of participating adequately in a daily exercise 
program during and after allo-HSCT. Two mixed type exercise studies implemented during 
the entire hospitalization suggest a stabilization in aerobic endurance during hospitalization 
(Jarden et al. 2009; Baumann et al. 2011), and one 12 week out-patient endurance study 
found significant positive cardiovascular effects (Carlson et al. 2006). In regards to muscle 
strength, mixed type exercise during hospitalization (Baumann et al. 2011; Jarden et al. 2009) 
and continuing in the outpatient context (Mello et al. 2003) showed significant muscle 
strength decreases in control group, but only one study found significant differences 
between groups (Jarden et al. 2009) suggesting that the loss of muscle strength was 
minimized. Mixed type exercise during hospitalization (Jarden et al. 2009) and continued 
after discharge (Wiskemann et al. 2011) significantly decreased loss of function (2 minute 
stair climb) (Jarden et al. 2009) and significantly maintained function (6MWT) (Wiskemann 
et al. 2011). DeFor et al.’s walking program during and after discharge did not show 
significant differences between groups for Karnofsky score, though a subgroup analysis of 
the nonmyeloablative group showed a significant reduction in loss of performance in the 
intervention group. (DeFor et al. 2007). Both supervised and self directed mixed type 
exercise in the post HSCT was shown to improve function significantly on the 6MWD and 
for the supervised group improvement was reported for the 50 foot walk time (Shelton et al. 
2009). A mixed type low intensity exercise program during hospitalization significantly 
decreased depression (BDI) and anxiety as compared to the control group (Kim and Kim 
2006), while two mixed-type moderate intensity exercise programs during hospitalization 
did not show a significant effect on HR-QoL (Baumann et al. 2011, Jarden et al. 2009), but 
Wiskemann et al.’s mixed type exercise that continued after discharge showed a significant 
improvement in physical functioning and decreased depression, but also a significant 
increase in anxiety (Wiskemann et al. 2011). DeFor’s in- to out-patient walking program 
reported significant improvements in emotional wellbeing among the nonmyeloablative 
patient group at hospital discharge and by 100 days, physical wellbeing was significantly 
improved. Carlson et al.’s 12 week out-patient endurance program significantly increased 
vigor. There was a significant longitudinal decrease in prevalence and intensity of several 
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symptoms and symptom clusters, including fatigue up to 6 months (Jarden et al. 2009) and 
in two studies exercising after discharge, a significant decrease in fatigue scores was 
reported (Wiskemann et al. 2011, Carlson et al. 2006). Hospital or treatment-related 
outcomes as body composition or immunological and infectious parameters i.e. lymphocyte 
counts, days to bone marrow engraftment, days with fever, incidence of GvHD., number of 
transfusions received)  was not affected by exercise. One exercising group received 
significantly fewer days of TPN as compared to the control group (Jarden et al. 2009). There 
was no effect on duration of hospitalization (Inoue et al. 2010, Jarden et al. 2009, Defor et al. 
2007), though Inoue et al. reported that the level of physical activity had a negative 
correlation with the number of hospitalization days (Inoue et al. 2010).   
It is suggested in recent literature that the optimal training program for persons with cancer 
combine both aerobic and muscle strength training (Neiman & Courneya, 2006, Courneya & 
Friedenreich, 2011). A review from 2008 of 15 exercise trials in the in-patient and out-patient 
HSCT setting, included patients in the allo-HSCT and HD-SCS context and resulted in 
tentative recommendations (Wiskemann & Huber, 2008): mixed exercise: endurance (up to 
daily) and resistance training (2-3 x/wk)), from 10 - 30 minutes at moderate intensity (BORG 
scale 12-14, 70-80% maximum HR) before, during and after hospitalization. In Liu et al. 
literature review from 2009 of physical exercise interventions in hæmatological cancer 
patients suggested it feasible to conduct exercise in this patient population, but concluded 
that there was a lack in methodological quality in the physical exercise studies and therefore 
effectiveness could not be established (Liu  et al. ). Recommendations based on a more 
recent review from 2011 of patients with mixed hematologic disease propose ‘supervised’ 
exercise during and after hematological cancer treatments 2 to 5 days per week, with 
adjustment for health conditions. Further, a combination of aerobic and resistance exercise is 
suggested, with a varying intensity between 40-70% of maximum heart rate and full body 
resistance exercises at 8-12 reps and 2-3 sets with slow progression over time. Health and 
neutropenic screening for exercise participation is also recommended according to Jones et 
al. (Battaglini 2011).  
Exercise recommendations, however for patients during and after hospitalization for 
specifically allo-HSCT have not been developed, and in order to determine the appropriate 
and optimal exercise prescription / intervention for patients undergoing allo-HSCT, trials in 
the allo-HSCT context were examined in this review for type, duration, frequency and 
intensity. Taken the methodological limitations into consideration, a partly to fully 
supervised and daily, mixed-type exercise (aerobic and resistant exercises, also ROM and 
stretching) at moderate intensity (70-75% MHR) started at least prior to conditioning and 
carried out during allo-HSCT is feasible and can maintain or decrease loss of aerobic 
capacity, muscle strength and function at hospital discharge. However, continuing the 
program after hospital discharge had further physical, functional and symptom related 
benefits (decrease fatigue, reduced depression). Attaining positive results require a 
relatively high compliance rate, over 85%. Therefore, screening parameters and 
contraindication for training criteria should be instituted to not only keep the patient safe, 
but also enable adequate participation in the program. Based on this review, it can be 
suggested that postponement or modification of training include: platelets < 20 x 109/l, 
haemoglobin < 5-8 g/l, temp > 38oC and adverse symptoms as bleeding, petecchiae, pain, 
nausea, dizziness. It is not clear from this review, whether training during conditioning inkl. 
cardio and nephrotoxic chemotherapy should be postponed, and to what extent, that is, 
during active infusion or hours/days following chemotherapy. We may also consider 
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incorporation of low intensity exercise as relaxation breathing or progressive relaxation in 
the program, especially when a higher exercise intensity level is not possible (Kim and Kim, 
2006; Jarden et al. 2009). Psychosocial, educational and motivational approaches may be 
integrated to maintain compliance levels, support exercise motivation and efficacy and 
increase independent activity and lifestyle changes.  
5. Conclusion and future research 
This chapter is a systematic review of the  rehabilitation  research carried out in the allo-
HSCT context during the past 25 years. These findings, despite a number of methodological 
issues, indicate positive physiological and emotional benefits from exercise in patients 
during and after allo-HSCT. Exercise during treatment may help patients decrease loss of or 
maintain aerobic and functional capacity, and muscle strength, and when exercise is 
continued or instituted in the outpatient/home context there are improvements in aerobic 
and functional capacity. These results also indicate that exercise-based interventions have 
multidimensional benefits, including maintaining or improving HRQOL and reducing the 
most persistent treatment-related symptoms, especially fatigue. This review provides 
general guidelines for exercise in the allo-HSCT context. However, with improved 
methodological approaches, future research may provide clinicians with more specific 
rehabilitation guidelines.   
5.1 Future research  
Future studies are encouraged to institute certain methodological stringencies, including 
inclusion of homogenous groups (same diagnosis or treatment group), larger patient 
populations, perhaps, multi-institutional studies, randomized designs that clearly describe 
treatment allocation and stratification methods, as well as details regarding the control 
group. Further, point estimates for primary outcomes, effect size calculations, as well as 
Intention-to-Treat analyses are recommended. When and if possible, an effort to blind 
outcome assessors, data entry keyers and statisticians would improve methodological 
quality. It is also important that future studies justify the chosen intervention and clearly 
describe the individual exercise components duration, intensity and frequency as well as 
screening parameters for intervention participation, and lastly, documentation of 
compliance rates in order to properly evaluate the effect of the intervention. Decisions 
regarding test time-points and the most relevant and comprehensive outcome 
measurements need to be associated with challenges directly related to allo-HSCT. 
Therefore, GvHD, treatment related symptoms i.e. fatigue, insomnia, pain, gastrointestinal 
complaints, skin and bodily changes, poor physical, functional and muscle capacity, low 
levels of physical activity and decreased bone density, low Vitamin D levels and reduced 
HRQOL including problems with sexuality, body image, social wellbeing and job function 
need to be considered in this treatment group. More studies are needed that examine the 
entire treatment trajectory and continue well into the out-patient and home setting. Research 
that aims to promote multidimensional benefits may consider multimodal interventional 
designs that combine physical exercise with other psychosocial and educational approaches. 
Additionally the role of vitamin D and exposure to sunlight in combination with physical 
exercise on bone health, function and general wellbeing may be warranted. Further, there is 
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a need to study the patients’ own experience as a participant in an exercise-based 
intervention in order to develop programs that are tailored to fit the needs of patients 
during and after allo-HSCT. Finally, translational intervention studies are needed that 
support and improve the ability of patients to cope with their life situation during 
treatment, as well as to function optimally after allo-HSCT in daily life, including return to 
employment.  
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